Upon systemic treatment with PI3K/AKT inhibitors, hyperglycaemia is induced by phosphorylation of insulin receptor (IR) leading to loss of insulin signalling in peripheral tissue and pancreatic β cells33, 34. Here, AKT1 is linked to Hyperglycemia.